MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q3 2018. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $134,530 | -17.4% | 5,500,000 | -28.0% | 3.72% | -6.7% |
Q1 2024 | $162,778 | +11.4% | 7,635,000 | 0.0% | 3.99% | +7.1% |
Q4 2023 | $146,134 | +37.3% | 7,635,000 | +15.1% | 3.72% | +6.2% |
Q3 2023 | $106,425 | -30.8% | 6,635,000 | 0.0% | 3.51% | -30.0% |
Q2 2023 | $153,799 | -5.4% | 6,635,000 | -5.2% | 5.01% | +0.1% |
Q1 2023 | $162,610 | +60.1% | 7,000,000 | 0.0% | 5.00% | +43.5% |
Q4 2022 | $101,570 | -99.9% | 7,000,000 | +40.0% | 3.48% | +19.3% |
Q3 2022 | $95,400,000 | +5.0% | 5,000,000 | 0.0% | 2.92% | -25.9% |
Q2 2022 | $90,850,000 | +3.0% | 5,000,000 | +42.9% | 3.94% | +23.6% |
Q1 2022 | $88,200,000 | +16.2% | 3,500,000 | +27.3% | 3.19% | +22.3% |
Q4 2021 | $75,900,000 | -14.5% | 2,750,000 | 0.0% | 2.61% | -4.6% |
Q3 2021 | $88,798,000 | -3.2% | 2,750,000 | -8.3% | 2.73% | -11.5% |
Q2 2021 | $91,740,000 | +0.4% | 3,000,000 | 0.0% | 3.09% | -1.4% |
Q1 2021 | $91,350,000 | -7.6% | 3,000,000 | -40.0% | 3.14% | -9.7% |
Q4 2020 | $98,875,000 | -24.2% | 5,000,000 | -50.0% | 3.47% | +0.9% |
Q3 2020 | $130,400,000 | +187.5% | 10,000,000 | +150.0% | 3.44% | +32.5% |
Q2 2020 | $45,360,000 | +34.9% | 4,000,000 | +70.2% | 2.60% | +29.2% |
Q1 2020 | $33,629,000 | +23.5% | 2,350,000 | +135.0% | 2.01% | +44.9% |
Q4 2019 | $27,230,000 | -4.9% | 1,000,000 | 0.0% | 1.39% | -8.0% |
Q3 2019 | $28,630,000 | -48.9% | 1,000,000 | -33.3% | 1.51% | -30.2% |
Q2 2018 | $56,055,000 | +26.5% | 1,500,000 | 0.0% | 2.16% | -0.9% |
Q1 2018 | $44,325,000 | -14.0% | 1,500,000 | 0.0% | 2.18% | -13.7% |
Q4 2017 | $51,518,000 | -28.8% | 1,500,000 | -25.0% | 2.52% | -45.0% |
Q3 2017 | $72,360,000 | -6.7% | 2,000,000 | -33.3% | 4.59% | +21.5% |
Q2 2017 | $77,520,000 | -6.6% | 3,000,000 | -30.6% | 3.77% | +12.1% |
Q1 2017 | $83,040,000 | +22.7% | 4,325,000 | +6.5% | 3.37% | -4.4% |
Q4 2016 | $67,680,000 | – | 4,060,000 | – | 3.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,500,000 | $134,530 | 3.72% |
Glenview Capital Management | 3,748,432 | $91,686,647 | 1.80% |
ORACLE INVESTMENT MANAGEMENT INC | 60,000 | $1,467,600 | 1.37% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 240,128 | $5,873,531 | 1.10% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,087,328 | $51,056,043 | 0.96% |
OBERWEIS ASSET MANAGEMENT INC/ | 360,700 | $8,822,722 | 0.54% |
EARNEST PARTNERS LLC | 4,072,018 | $99,601,560 | 0.47% |
AIMZ Investment Advisors, LLC | 39,585 | $968,249 | 0.35% |
Eversept Partners, LP | 181,961 | $4,450,766 | 0.30% |
Hillsdale Investment Management Inc. | 151,180 | $3,697,863 | 0.29% |